Literature DB >> 30341890

Impact of reproductive evolutionary mismatch on women's health and the need for action and research.

Mahmoud F Fathalla1.   

Abstract

Efforts by the health and scientific community have focused on providing women with the means to control and regulate their fertility. We paid less attention to the reality of women achieving their reproductive revolution while burdened with a reproductive system that evolved to fit the life of our ancestor hunter-gatherers, where women were destined to spend most of their reproductive years pregnant or breastfeeding. This state of evolutionary mismatch impacts on women's health as the reproductive system continues incessantly to work, producing a monthly ovum and exposing the reproductive organs to cyclic hormonal stimulation without the benefit of pregnancy and breastfeeding. Women have to cope with a life of menstrual cycles, decreased fecundity owing to reproductive ageing, and a higher risk of reproductive cancers, in addition to uterine fibroids, and endometriosis. The burden will increase in low-resource countries as more women are adopting the new model of reproductive behavior, and resources to cope with the impact are limited. The reproductive revolution is benefiting not only women, but also their societies and the world at large. The health profession and the scientific community have an obligation to support women to cope with the impact of reproductive evolutionary mismatch.
© 2018 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Evolutionary mismatch; Fertility control; Reproductive ageing; Reproductive cancers; Reproductive revolution; Women's health

Mesh:

Year:  2018        PMID: 30341890     DOI: 10.1002/ijgo.12694

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  1 in total

1.  Hymenolepis diminuta-based helminth therapy in C3(1)-TAg mice does not alter breast tumor onset or progression.

Authors:  Scott Sauer; Dylan Beinart; Sade M B Finn; Sereena L Kumar; Qing Cheng; Shelley E Hwang; William Parker; Gayathri R Devi
Journal:  Evol Med Public Health       Date:  2021-02-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.